Rigel Pharmaceuticals (RIGL) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to -$137.1 million.
- Rigel Pharmaceuticals' Enterprise Value fell 12440.52% to -$137.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$137.1 million, marking a year-over-year decrease of 12440.52%. This contributed to the annual value of -$77.3 million for FY2024, which is 3581.05% down from last year.
- Rigel Pharmaceuticals' Enterprise Value amounted to -$137.1 million in Q3 2025, which was down 12440.52% from -$108.4 million recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Enterprise Value registered a high of -$39.3 million during Q1 2021, and its lowest value of -$153.4 million during Q2 2021.
- Over the past 5 years, Rigel Pharmaceuticals' median Enterprise Value value was -$77.1 million (recorded in 2025), while the average stood at -$84.2 million.
- As far as peak fluctuations go, Rigel Pharmaceuticals' Enterprise Value soared by 5898.4% in 2021, and later crashed by 17327.23% in 2022.
- Quarter analysis of 5 years shows Rigel Pharmaceuticals' Enterprise Value stood at -$125.0 million in 2021, then surged by 53.42% to -$58.2 million in 2022, then rose by 2.19% to -$56.9 million in 2023, then plummeted by 35.81% to -$77.3 million in 2024, then crashed by 77.37% to -$137.1 million in 2025.
- Its Enterprise Value was -$137.1 million in Q3 2025, compared to -$108.4 million in Q2 2025 and -$77.1 million in Q1 2025.